Survival (A) and freedom from AML evolution (B) of MDS patients related to their individual cytogenetic categories (Kaplan-Meier curves). The number of patients in each category and their proportional representation (in parentheses) are given for the 816 patients analyzed for survival (A). Virtually identical proportions of cytogenetic abnormalities were found for the 759 patients analyzed for AML evolution (B).